These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 32808486)

  • 1. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive nanoplatforms for antibacterial applications.
    Huang Y; Zou L; Wang J; Jin Q; Ji J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
    Chen Z; Wang X; Zhao N; Chen H; Guo G
    Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
    Ismail EA; Devnarain N; Govender T; Omolo CA
    J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
    Lu X; Guo X; Wan D; Pan J
    Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
    Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
    J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
    Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
    Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy.
    Bhattacharya S; Prajapati BG; Singh S
    Crit Rev Oncol Hematol; 2023 May; 185():103961. PubMed ID: 36921781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
    Qin X; Li Y
    Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.